Brain cancer vaccine (Stemline Therapeutics)

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameBrain cancer vaccine (Stemline Therapeutics)

Drug Alias Name脑肿瘤疫苗 - Stemline TherapeuticsSL-701

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Pittsburgh

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesStemline Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A